This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benlhassan-Chahour, K.
Right arrow Articles by Vaslin, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benlhassan-Chahour, K.
Right arrow Articles by Vaslin, B.

 Previous Article  |  Next Article 

Journal of Virology, December 2003, p. 12479-12493, Vol. 77, No. 23
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.23.12479-12493.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Kinetics of Lymphocyte Proliferation during Primary Immune Response in Macaques Infected with Pathogenic Simian Immunodeficiency Virus SIVmac251: Preliminary Report of the Effect of Early Antiviral Therapy

Kadija Benlhassan-Chahour,1 Claude Penit,2 Vincent Dioszeghy,1 Florence Vasseur,2 Geneviève Janvier,3 Yves Rivière,3 Nathalie Dereuddre-Bosquet,4 Dominique Dormont,1 Roger Le Grand,1 and Bruno Vaslin1*

CEA, Service de Neurovirologie, Laboratoire d'Immunopathologie Expérimentale, DSV/DRM, CRSSA, EPHE, IPSC, Paris XI University,1 SPI-BIO c/o Service de Neurovirologie, CEA, 92265 Fontenay aux Roses,4 INSERM, U591, Faculté de Médecine Necker,2 Laboratoire d'Immunopathologie Virale, URA CNRS 1930, Institut Pasteur, 75015 Paris, France3

Received 28 March 2003/ Accepted 26 August 2003

The aim of this study was to evaluate the kinetics of lymphocyte proliferation during primary infection of macaques with pathogenic simian immunodeficiency virus (SIV) and to study the impact of short-term postexposure highly active antiretroviral therapy (HAART) prophylaxis. Twelve macaques were infected by intravenous route with SIVmac251 and given treatment for 28 days starting 4 h postexposure. Group 1 received a placebo, and groups 2 and 3 received combinations of zidovudine (AZT), lamivudine (3TC), and indinavir. Macaques in group 2 received AZT (4.5 mg/kg of body weight), 3TC (2.5 mg/kg), and indinavir (20 mg/kg) twice per day by the oral route whereas macaques in group 3 were given AZT (4.5 mg/kg) and 3TC (2.5 mg/kg) subcutaneously twice per day, to improve the pharmacokinetic action of these drugs, and a higher dose of indinavir (60 mg/kg). The kinetics of lymphocyte proliferation were analyzed by monitoring 5-bromo-2'-deoxyuridine (BrdU) uptake ex vivo and by fluorescence-activated cell sorting analysis. HAART did not protect against SIV infection but did strongly impact on virus loads: viremia was delayed and lowered during antiviral therapy in group 2, with better control after treatment was stopped, and in group 3, viremia was maintained at lower levels during treatment, with virus even undetectable in the blood of some macaques, but there was no evidence of improved control of the virus after treatment. We provide direct evidence that dividing NK cells are detected earlier than dividing T cells in the blood (mostly in CD45RA- T cells), mirroring plasma viremia. Dividing CD8+ T cells were detected earlier than dividing CD4+ T cells, and the highest percentages of proliferating T cells coincided with the first evidence of partial control of peak viremia and with an increase in the percentage of circulating gamma interferon-positive CD8+ T cells. The level of cell proliferation in the blood during SIV primary infection was clearly associated with viral replication levels because the inhibition of viral replication by postexposure HAART strongly reduced lymphocyte proliferation. The results and conclusions in this study are based on experiments in a small numbers of animals and are thus preliminary.

* Corresponding author. Mailing address: Service de Neurovirologie, DSV/DRM, CEA, CRSSA, EPHE, IPSC, 18, route du panorama, BP 6, 92265 Fontenay-aux-Roses Cedex, France. Phone: 33 1 46 54 94 78. Fax: 33 1 46 54 77 26. E-mail: vaslin{at}dsvidf.cea.fr.

Journal of Virology, December 2003, p. 12479-12493, Vol. 77, No. 23
0022-538X/03/$08.00+0     DOI: 10.1128/JVI.77.23.12479-12493.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Malleret, B., Maneglier, B., Karlsson, I., Lebon, P., Nascimbeni, M., Perie, L., Brochard, P., Delache, B., Calvo, J., Andrieu, T., Spreux-Varoquaux, O., Hosmalin, A., Le Grand, R., Vaslin, B. (2008). Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression. Blood 112: 4598-4608 [Abstract] [Full Text]  
  • Karlsson, I., Malleret, B., Brochard, P., Delache, B., Calvo, J., Le Grand, R., Vaslin, B. (2007). FoxP3+ CD25+ CD8+ T-Cell Induction during Primary Simian Immunodeficiency Virus Infection in Cynomolgus Macaques Correlates with Low CD4+ T-Cell Activation and High Viral Load. J. Virol. 81: 13444-13455 [Abstract] [Full Text]  
  • Karlsson, I., Malleret, B., Brochard, P., Delache, B., Calvo, J., Le Grand, R., Vaslin, B. (2007). Dynamics of T-Cell Responses and Memory T Cells during Primary Simian Immunodeficiency Virus Infection in Cynomolgus Macaques. J. Virol. 81: 13456-13468 [Abstract] [Full Text]  
  • Florese, R. H., Van Rompay, K. K. A., Aldrich, K., Forthal, D. N., Landucci, G., Mahalanabis, M., Haigwood, N., Venzon, D., Kalyanaraman, V. S., Marthas, M. L., Robert-Guroff, M. (2006). Evaluation of Passively Transferred, Nonneutralizing Antibody-Dependent Cellular Cytotoxicity-Mediating IgG in Protection of Neonatal Rhesus Macaques against Oral SIVmac251 Challenge. J. Immunol. 177: 4028-4036 [Abstract] [Full Text]  
  • Dioszeghy, V., Benlhassan-Chahour, K., Delache, B., Dereuddre-Bosquet, N., Aubenque, C., Gras, G., Le Grand, R., Vaslin, B. (2006). Changes in Soluble Factor-Mediated CD8+ Cell-Derived Antiviral Activity in Cynomolgus Macaques Infected with Simian Immunodeficiency Virus SIVmac251: Relationship to Biological Markers of Progression. J. Virol. 80: 236-245 [Abstract] [Full Text]  
  • Miller, N. E., Bonczyk, J. R., Nakayama, Y., Suresh, M. (2005). Role of Thymic Output in Regulating CD8 T-Cell Homeostasis during Acute and Chronic Viral Infection. J. Virol. 79: 9419-9429 [Abstract] [Full Text]  
  • Mueller, Y. M., Petrovas, C., Bojczuk, P. M., Dimitriou, I. D., Beer, B., Silvera, P., Villinger, F., Cairns, J. S., Gracely, E. J., Lewis, M. G., Katsikis, P. D. (2005). Interleukin-15 Increases Effector Memory CD8+ T Cells and NK Cells in Simian Immunodeficiency Virus-Infected Macaques. J. Virol. 79: 4877-4885 [Abstract] [Full Text]  
  • Gomez-Roman, V. R., Patterson, L. J., Venzon, D., Liewehr, D., Aldrich, K., Florese, R., Robert-Guroff, M. (2005). Vaccine-Elicited Antibodies Mediate Antibody-Dependent Cellular Cytotoxicity Correlated with Significantly Reduced Acute Viremia in Rhesus Macaques Challenged with SIVmac251. J. Immunol. 174: 2185-2189 [Abstract] [Full Text]  
  • de Groot-Mijnes, J. D. F., van Dun, J. M., van der Most, R. G., de Groot, R. J. (2005). Natural History of a Recurrent Feline Coronavirus Infection and the Role of Cellular Immunity in Survival and Disease. J. Virol. 79: 1036-1044 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»